Position in NTLA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$31,293,657
+$8,460,430 QoQ
Shares Held
1,849,507
+3.8% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#20
of 327 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JUPITER ASSET MANAGEMENT LTD holds $354,007,590 across 28 Biotechnology names. NTLA ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,099 | $78,627,770 | |
| 2 | INCY |
Incyte Corp
|
511,050 | $57,932,627 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
707,450 | $57,706,695 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
This page
|
1,849,507 | $31,293,657 | |
| 5 | IOVA |
Iovance Biotherapeutics, Inc.
|
4,535,080 | $18,865,932 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,094,475 | $18,573,240 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
445,718 | $15,297,041 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
719,576 | $13,463,266 |
All Filings in NTLA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,293,657 | 1,849,507 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $22,833,227 | 1,781,063 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,330,882 | 1,037,918 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $23,519,132 | 1,361,849 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||